Bladder Cancer - Results from #740

REVIEW UroToday

CG Oncology Announces Presentation of the First Phase 3 Monotherapy Data for Cretostimogene Grenadenorepvec in BCG-Unresponsive NMIBC Patients at SUO 2023 November 15, 2023

Evidence-Based Analysis of the Critical Steps of Radical Cystectomy for Bladder Cancer. November 15, 2023

The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study. November 15, 2023

Survival Outcomes and Parameters of Switch Maintenance - Expert Commentary November 14, 2023

Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer. November 14, 2023

Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma. November 14, 2023

Urinary Tumor DNA for the Detection of Field Cancerization - Expert Commentary November 13, 2023

Upstaging after TUR-BT for non-muscle invasive cancer of the bladder - Who is at highest risk? November 13, 2023

Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation. November 13, 2023

3D laparoscopic treatment of bladder cancer with pelvic multi-organ invasion: a case report and literature review. November 10, 2023

Evaluation of FGFR Alteration Status in Urothelial Tumors. November 9, 2023

Influence of Neoadjuvant Chemotherapy on Survival Outcomes of Radical Cystectomy in Pathologically Proven Positive and Negative Lymph Nodes. November 9, 2023

Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site. November 8, 2023

Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer. November 8, 2023

Predictive models of long-term survival outcomes following radical cystectomy. November 7, 2023

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. November 7, 2023

Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Elective and Eligibility Factors Impacting Utilization. November 6, 2023

Budgetary Impact of Including the Urinary Genomic Marker Cxbladder Detect in the Evaluation of Microhematuria Patients. November 6, 2023

Intra-arterial chemotherapy plus BCG, a promising combination adjuvant treatment for high-risk NMIBC. November 6, 2023

Do Histology and Primary Tumor Location Influence Metastatic Patterns in Bladder Cancer? November 3, 2023

Page 38 of 517